Apr 13, 2017
"Though this be madness, yet there is method in't." Shakespeare didn't know it, but he was already talking about thymectomy in Hamlet. In this week's BrainWaves episode, you'll hear about the pharmacologic fundamentals, and the most recent guidelines for treatment of myasthenia. BrainWaves podcasts and online content are intended for medical education only and should not be used to guide medical decision making in routine clinical practice. REFERENCES 1. Schneider-Gold C, Gajdos P, Toyka KV and Hohlfeld RR. Corticosteroids for myasthenia gravis. The Cochrane database of systematic reviews. 2005:CD002828. 2. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Strobel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A, 3rd, Newsom-Davis J, Cutter GR and Group MS. Randomized Trial of Thymectomy in Myasthenia Gravis. The New England journal of medicine. 2016;375:511-22.